Catalyst Wire Dossier Catalyst Wire Dossier

Nilontinib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nilontinib, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors [Phase 1]

See pricing